Close
  • Home

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

Funding

Deals  ·  Weekly Digest - 07 November to 13 November 2026
ProBio secures exclusive global license from AbTis for next-generation ADC development

Weekly Digest – November 2026 Weekly Digest – November 2026 10 November 2026: ProBio secures exclusive global license from AbTis for next-generation ADC development ProBio has entered into an exclusive global licensing agreement with South Korea-based AbTis, granting AbTis worldwide development […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 07 November to 13 November 2026
MindRank and BoomRay partner to develop AI-driven Cyclic Peptide Radioligand Conjugates for oncology

Weekly Digest – November 2026 Weekly Digest – November 2026 11 November 2026: MindRank and BoomRay partner to develop AI-driven Cyclic Peptide Radioligand Conjugates for oncology Hangzhou MindRank Technology and Suzhou BoomRay Pharma announced a strategic research collaboration to jointly develop […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 31 October to 06 November 2026
NMPA grants priority review to Hengrui’s Trastuzumab Rezetecan NDA for 1L HER2-positive breast cancer

Weekly Digest – November 2026 Weekly Digest – November 2026 30 October 2026: NMPA grants Priority Review to Hengrui’s Trastuzumab Rezetecan NDA for 1L HER2-positive Breast cancer Hengrui Medicine’s subsidiary, Suzhou Shengdiya, received NMPA acceptance and Priority Review for SHR-A1811, a HER2-targeted […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 31 October to 06 November 2026
SEC recommends approval for additional indication of AstraZeneca’s anti-cancer drug

Weekly Digest – November 2026 Weekly Digest – November 2026 03 November 2026: SEC recommends approval for additional indication of AstraZeneca’s anti-cancer drug The Subject Expert Committee recommended approval of an additional indication for AstraZeneca’s datopotamab deruxtecan in adults with unresectable or […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 31 October to 06 November 2026
Alphamab oncology announces IND application for innovative EGFR/HER3 dual payload bispecific ADC JSKN021 was approved by the FDA

Weekly Digest – November 2026 Weekly Digest – November 2026 02 November 2026: Alphamab oncology announces IND application for innovative EGFR/HER3 dual payload bispecific ADC JSKN021 was approved by the FDA Alphamab Oncology announced that the FDA has approved the IND application for […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest - 31 October to 06 November 2026
CSPC Pharmaceutical Group has initiated phase 1/2 clinical trial of SYS6043 for the Solid tumor in China

Weekly Digest – November 2026 Weekly Digest – November 2026 30 October 2026: CSPC Pharmaceutical Group has initiated Phase 1/2 clinical trial of SYS6043 for the Solid tumor in China CSPC Pharmaceutical Group has initiated the first-site Phase 1/2 clinical […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 31 October to 06 November 2026
Sino biopharmaceutical enters strategic oncology partnership with Boehringer Ingelheim valued at up to US$7 billion

Weekly Digest – November 2026 Weekly Digest – November 2026 04 November 2026: Sino Biopharmaceutical enters strategic oncology partnership with Boehringer Ingelheim valued at up to US$7 billion Sino Biopharmaceutical entered its second oncology collaboration with Boehringer Ingelheim, covering six […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 31 October to 06 November 2026
Telix Joins Thera4Care with TLX400-Tx to accelerate translation of next generation FAP-targeting theranostics

Weekly Digest – November 2026 Weekly Digest – November 2026 05 November 2026: Telix Joins Thera4Care with TLX400-Tx to accelerate translation of next generation FAP-targeting theranostics Telix joined Thera4Care, a European theranostics initiative involving 27 partners, to advance collaborative research and […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest - 24 October to 30 October 2026
Enhertu received EU approval as adjuvant treatment for HER2-positive early Breast cancer

Weekly Digest – October 2026 Weekly Digest – October 2026 22 October 2026: BioNTech and Gilead partner to evaluate Pumitamig plus Trodelvy in 1L TNBC BioNTech announced a clinical trial collaboration and supply agreement with Gilead Sciences to evaluate pumitamig […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 24 October to 30 October 2026
NMPA accepted the new indication application for sac-TMT plus pembrolizumab as 1L treatment for PD-L1-negative non-squamous NSCLC

Weekly Digest – October 2026 Weekly Digest – October 2026 27 October 2026: NMPA accepted the new indication application for sac-TMT plus pembrolizumab as 1L treatment for PD-L1-negative non-squamous NSCLC Kelun-Biotech announced that China’s NMPA has accepted for review a […]

by Sandhya Ramalingam

Continue Reading
‹ Previous123456Next ›Last »
Page 2 of 63


Contact:

  info@ciscientists.com

 +1-908-212-7484

Optimal Dose

For a subscription, please provide your email id